Bank of Montreal’s Korsana Biosciences, Inc. Common Stock KRSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-4
Closed -$2K – 3964
2021
Q1
$2K Sell
4
-20
-83% -$10.5K ﹤0.01% 4893
2020
Q4
$11K Buy
24
+16
+200% +$7.64K ﹤0.01% 4630
2020
Q3
$7K Sell
8
-4
-33% -$3.2K ﹤0.01% 4269
2020
Q2
$10K Buy
+12
New +$7.02K ﹤0.01% 4161
2020
Q1
– Sell
-22
Closed -$8K – 4216
2019
Q4
$8K Buy
22
+7
+47% +$4.58K ﹤0.01% 4617
2019
Q3
$26K Sell
15
-1
-6% -$1.51K ﹤0.01% 3941
2019
Q2
$25K Buy
+16
New +$31.7K ﹤0.01% 4047

Other funds holding KRSA

Bank of Montreal's KRSA Position: Q2 2021 in Review

Bank of Montreal sold out of Korsana Biosciences, Inc. Common Stock (KRSA) in Q2 2021, closing a stake of 4 shares — an estimated $2K sold.

Bank of Montreal first reported a position in KRSA in Q2 2019 and held it in 7 quarters. The position peaked at $26K in Q3 2019. 65 funds tracked by Wall St. Rank hold KRSA as of Q2 2021.

  • Bank of Montreal reported no remaining Korsana Biosciences, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 4 Korsana Biosciences, Inc. Common Stock shares in Q2 2021, an estimated $2K.
  • Bank of Montreal first reported a position in Korsana Biosciences, Inc. Common Stock in Q2 2019 and held it in 7 quarters.
  • Bank of Montreal's Korsana Biosciences, Inc. Common Stock position peaked at $26K in Q3 2019.
  • 65 funds tracked by Wall St. Rank held Korsana Biosciences, Inc. Common Stock as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.